Skip to main content

Table 2 Awareness of PrEP and other prevention strategies, and comfort with HIV/STI procedures among HIV physicians from Brazil and Mexico, 2020

From: Awareness, knowledge, and attitudes related to HIV pre-exposure prophylaxis and other prevention strategies among physicians from Brazil and Mexico: cross-sectional web-based survey

  Total Brazil Mexico P valuea
(N = 481)
n (%)
(N = 339; 70.5%)
n (%)
(N = 142; 29.5%)
n (%)
 
Awareness of PrEP and other prevention strategies (yes)
 PEP 419 (87.1) 302 (89.1) 117 (82.4) .05
 Combination HIV prevention concept 407 (84.6) 294 (86.7) 113 (79.6) .05
 Condoms and lubricants 407 (84.6) 303 (89.4) 104 (73.2) <.001
 PrEP 407 (84.6) 291 (85.8) 116 (81.7) .25
 Regular HIV/STI testing 393 (81.7) 299 (88.2) 94 (66.2) <.001
 Mother to child transmission 371 (77.1) 286 (84.4) 85 (59.9) <.001
 Knowledge of partner serology 356 (74) 275 (81.1) 81 (57) <.001
 Treatment as prevention 347 (72.1) 280 (82.6) 67 (47.2) <.001
 Vaccination for HAVb, HBVc and HPVd 335 (69.7) 270 (79.6) 65 (45.8) <.001
 Cervical exams 233 (48.4) 185 (54.6) 48 (33.8) <.001
Awareness of PrEP Technologies (yes)
 Daily oral with TDF/FTCe 444 (92.3) 313 (92.3) 131 (92.3) .98
 Event-Driven PrEP with TDF/FTCe 262 (54.5) 212 (62.5) 50 (35.2) <.001
 Daily oral with TAF/FTCf 246 (51.1) 171 (50.4) 75 (52.8) .63
 Cabotegravir injection 202 (42) 180 (53.1) 22 (15.5) <.001
 Vaginal ring with antiretroviral 156 (32.4) 120 (35.4) 36 (25.4) .03
 Microbicides 104 (21.6) 82 (24.2) 22 (15.5) .03
 Implants with antiretroviral 97 (20.2) 81 (23.9) 16 (11.3) <.01
 Monoclonal antibodies 61 (12.7) 57 (16.8) 4 (2.8) <.001
Comfort with HIV/STI prevention procedures (yes)
 Request HIV exam 477 (99.2) 337 (99.4) 140 (98.6) .36
 Request STI exams 473 (98.3) 335 (98.8) 138 (97.2) .20
 Evaluation of sexual risk behavior 458 (95.2) 324 (95.6) 134 (94.4) .57
 Risk-reduction counseling 458 (95.2) 317 (93.5) 141 (99.3) <.01
 Discuss sexual behavior 454 (94.4) 320 (94.4) 134 (94.4) .99
 Discuss sexual orientation 453 (94.2) 317 (93.5) 136 (95.8) .33
 Provide HIV+ result 441 (91.7) 310 (91.5) 131 (92.3) .77
 Evaluation of PrEP eligibility 432 (89.8) 301 (88.8) 131 (92.3) .25
 U=Ug counseling 387 (80.5) 274 (80.8) 113 (79.6) .75
 Request HIV acute infection testh 333 (69.2) 333 (98.2) N/Ai
 Evaluation of PEP eligibilityh 320 (66.5) 320 (94.4) N/A
  1. aChi-square tests for all comparisons, except for Monoclonal antibodies (Fisher’s exact test)
  2. bHAV Hepatitis A virus
  3. cHBV Hepatitis B virus
  4. dHPV Human papilloma virus
  5. eTDF/FTC Tenofovir disoproxil fumarate / emtricitabine
  6. fTAF/FTC Tenofovir alafenamide / emtricitabine
  7. gU=U Undetectable equals untransmittable
  8. hThis question was not available in Mexico
  9. iN/A Not applicable